与新型冠状病毒肺炎相关的特发性血小板减少性紫癜
Idiopathic Thrombocytopenic Purpura Related to COVID-19.
作者信息
Langhi Mariana M, Abdo Andre N R, Putz Juliana F B, Carvalho Lizandra M, Loss Silvia R, Zampieri Filho Jose P, Bordin Jose O, Bachour Phillip, Baiocchi Otavio C C G
机构信息
Oncology Center at Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil.
出版信息
J Med Cases. 2020 Jul;11(7):204-206. doi: 10.14740/jmc3518. Epub 2020 Jun 29.
Abstract
Since December 2019, a newly identified coronavirus disease 2019 (COVID-19) has spread in China and the rest of world. There are many doubts regarding pathogenesis as well complications due to COVID-19. We report a case with association between thrombocytopenia and the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after exclusion of other possible etiology in a patient with previous controlled idiopathic thrombocytopenic purpura.
摘要
自2019年12月以来，一种新发现的冠状病毒病2019（COVID-19）在中国及世界其他地区传播。关于COVID-19的发病机制以及并发症存在许多疑问。我们报告了一例既往特发性血小板减少性紫癜病情得到控制的患者，在排除其他可能病因后，发现血小板减少与新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染有关。
相似文献
1
Idiopathic Thrombocytopenic Purpura Related to COVID-19.与新型冠状病毒肺炎相关的特发性血小板减少性紫癜
J Med Cases. 2020 Jul;11(7):204-206. doi: 10.14740/jmc3518. Epub 2020 Jun 29.
2
Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.儿童 SARS-CoV-2 阳性患者的免疫性血小板减少症（ITP）。
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-1419. Epub 2020 May 21.
3
Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus.一名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和爱泼斯坦-巴尔病毒（Epstein-Barr virus）患者的免疫性血小板减少性紫癜
Cureus. 2021 Feb 28;13(2):e13615. doi: 10.7759/cureus.13615.
4
[Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].无症状新冠病毒感染后出现的免疫性血小板减少症
Rinsho Ketsueki. 2021;62(1):58-60. doi: 10.11406/rinketsu.62.58.
5
SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura.严重急性呼吸综合征冠状病毒2型所致的严重免疫性血小板减少性紫癜
J Med Cases. 2020 Jun;11(6):166-168. doi: 10.14740/jmc3481. Epub 2020 May 28.
6
Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP.一名既往ITP病情稳定的患者在接种新冠疫苗后出现急性免疫性血小板减少症（ITP）
Open Forum Infect Dis. 2021 Jun 24;8(7):ofab343. doi: 10.1093/ofid/ofab343. eCollection 2021 Jul.
7
SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series.严重急性呼吸综合征冠状病毒2感染诱发免疫性血小板减少性紫癜：病例系列
Ochsner J. 2021 Summer;21(2):187-189. doi: 10.31486/toj.20.0100.
8
Idiopathic thrombocytopenic purpura as a hematologic manifestation of COVID-19 infection: A case report.特发性血小板减少性紫癜作为新型冠状病毒肺炎感染的血液学表现：一例报告
Respir Med Case Rep. 2021;34:101534. doi: 10.1016/j.rmcr.2021.101534. Epub 2021 Oct 21.
9
Immune Thrombocytopenic Purpura - Different Presentations in Two COVID-19 Patients.免疫性血小板减少性紫癜——两名新冠肺炎患者的不同表现
Cureus. 2020 Oct 27;12(10):e11202. doi: 10.7759/cureus.11202.
10
Omicron-Induced Immune Thrombocytopenia: A Case Report.奥密克戎诱导的免疫性血小板减少症：一例报告
Cureus. 2023 May 29;15(5):e39648. doi: 10.7759/cureus.39648. eCollection 2023 May.
本文引用的文献
1
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
2
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
3
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.沙特阿拉伯 47 例中东呼吸综合征冠状病毒病的流行病学、人口统计学和临床特征：描述性研究。
Lancet Infect Dis. 2013 Sep;13(9):752-61. doi: 10.1016/S1473-3099(13)70204-4. Epub 2013 Jul 26.
6
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.美国血液学会 2011 年免疫性血小板减少症循证实践指南。
Blood. 2011 Apr 21;117(16):4190-207. doi: 10.1182/blood-2010-08-302984. Epub 2011 Feb 16.
7
Immune thrombocytopenia.免疫性血小板减少症。
Hematology Am Soc Hematol Educ Program. 2010;2010:377-84. doi: 10.1182/asheducation-2010.1.377.
8
The ITP syndrome: pathogenic and clinical diversity.免疫性血小板减少症综合征：发病机制与临床多样性
Blood. 2009 Jun 25;113(26):6511-21. doi: 10.1182/blood-2009-01-129155. Epub 2009 Apr 24.
9
Pathobiology of secondary immune thrombocytopenia.继发性免疫性血小板减少症的病理生物学
Semin Hematol. 2009 Jan;46(1 Suppl 2):S2-14. doi: 10.1053/j.seminhematol.2008.12.005.
10
Autoimmune thrombocytopenic purpura in homosexual men.同性恋男性中的自身免疫性血小板减少性紫癜
Ann Intern Med. 1982 Jun;96(6 Pt 1):714-7. doi: 10.7326/0003-4819-96-6-714.
Zotero 插件